Vigor Compounding demonstrates its commitment to excellence in pharmacy compounding through a rigorous approach to product quality and testing. Operating from a cutting-edge 503A Compounding Pharmacy, the company adheres to the most stringent guidance outlined in USP <797>, ensuring that every medication produced meets or exceeds the highest industry benchmarks.
Vigor Compounding's operations are sterile compounding processes that highlight the company's dedication to patient safety. By employing advanced clean room technology to meet or exceed USP <797> requirements, Vigor Compounding maintains environments classified to ISO 5, ISO 7 and ISO 8 standards. This level of environmental control significantly reduces the risk of contamination, safeguarding the sterility of each compound produced.
Vigor Compounding further exemplifies its commitment to quality by using pharmaceutical-grade glass vials for all medications. These vials offer superior protection against potential leaching compared to plastic alternatives and help maintain compound stability over time. Each vial is carefully filled and sealed under aseptic conditions, assuring the sterility of its contents.
The company stands out in the industry with its innovative approach to dosing. Vigor Compounding's unique level-based dosing system provides accurate and consistent medication delivery across all strength levels. This system ensures patients receive precise doses throughout their treatment, from initial low doses to higher therapeutic levels, while maintaining a consistent injection volume.
Quality control is embedded in every step of Vigor Compounding's production process. Each formulation of medication undergoes thorough testing by an accredited third-party laboratory for sterility and endotoxin levels. These tests adhere to USP <71>, USP <85>, and ISO 17025 standards, providing an additional layer of assurance for healthcare providers and patients.
